Harvard Bioscience, Inc. (HBIO) vs iTonic Holdings Ltd. (ITOC)

A side-by-side comparison of Harvard Bioscience, Inc. and iTonic Holdings Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

HBIO

Harvard Bioscience, Inc.

$39M

$8.62HealthcareDelayed quote: Oct 6, 2026, 12:12 PM EDT

ITOC

iTonic Holdings Ltd.

$26M

$3.74HealthcareDelayed quote: Oct 6, 2026, 12:14 PM EDT

Total return — HBIO vs ITOC

growth of $100 · dividends reinvested · last 1y

HBIO +8.0% (+8.0%/yr)ITOC -42.6% (-42.6%/yr)HBIO compounded faster over this window

HBIO ITOC

HBIO vs ITOC: by the numbers

•HBIO is the larger company ($39M vs $26M market cap).
•Both run net losses; HBIO's is the smaller (-11.86% vs -974.68% net margin).

Metrics side by side

Valuation

Metric	HBIO	ITOC
P/S ratio	0.44	N/A
P/B ratio	5.24	1.08
EV / EBITDA	10.58	N/A

Profitability

Metric	HBIO	ITOC
Gross margin	58.16%	62.59%
Operating margin	1.17%	-991.71%
Net margin	-11.86%	-974.68%
ROE	-140.36%	-83.26%
ROIC	1.99%	-59.10%

Growth (annualized)

Metric	HBIO	ITOC
Revenue CAGR (5Y)	-4.62%	N/A
Total return CAGR (5Y)	-34.33%	N/A

Go deeper

Full HBIO analysis Full ITOC analysis Interactive comparison tool

Dig into the metrics

Harvard Bioscience ROE iTonic ROE Harvard Bioscience operating margin iTonic operating margin Harvard Bioscience revenue growth iTonic revenue growth Harvard Bioscience free cash flow iTonic free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.